Holen Sie sich die Stockscreener-App
11.95
4.09%
-0.33
Schlusskurs vom Vortag:
$11.62
Offen:
$11.62
24-Stunden-Volumen:
2,179
Relative Volume:
0.01
Marktkapitalisierung:
$523.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.74M
KGV:
-7.6027
EPS:
-1.5718
Netto-Cashflow:
$-24.89M
1W Leistung:
-13.60%
1M Leistung:
-15.76%
6M Leistung:
-28.28%
1J Leistung:
+56.97%
1-Tages-Spanne:
$11.36
$11.83
1-Wochen-Bereich:
$10.10
$13.06
52-Wochen-Spanne:
$6.82
$16.94
Third Harmonic Bio Inc Stock (THRD) Company Profile
Firmenname
Third Harmonic Bio Inc
Sektor
Branche
Telefon
(209) 727-2457
Adresse
1700 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie THRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| THRD | 11.83 | 523.58M | 0 | -32.74M | -24.89M | -1.5718 |
| VRTX | 448.13 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 742.12 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.43 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.32 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.27 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-10 | Eingeleitet | Cowen | Outperform |
| 2022-10-10 | Eingeleitet | Jefferies | Buy |
| 2022-10-10 | Eingeleitet | Morgan Stanley | Overweight |
Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten
(THRD) Technical Pivots with Risk Controls - Stock Traders Daily
RA Capital Management Reduces Stake in Third Harmonic Bio Inc - GuruFocus.com
Significant Stake Increase by T. Rowe Price in Third Harmonic Bi - GuruFocus.com
Vertiv Rises 13% in a Month: Time for Investors to Buy the Stock? - MSN
Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade - Yahoo Finance
Shiba Inu (SHIB) Price Rises 53% but Hits Rejection at Key Ascending Resistance Level - MSN
Third Harmonic Bio Reports Q3 2024 Financial Results - TipRanks
Third Harmonic Bio Inc (THRD) Quarterly 10-Q Report - Quartzy
Third Harmonic Bio (THRD) to Present at Major Stifel, Jefferies Healthcare Conferences | THRD Stock News - StockTitan
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Third Harmonic Flat on Q3 Results - Baystreet.ca
Third Harmonic Bio Announces Third Quarter 2024 Financial Results - The Manila Times
Third Harmonic Bio Reports $296M Cash Position, Phase 1 Trial Progress Despite Wider Q3 Loss | THRD Stock News - StockTitan
An RNAi renaissance is creating a new generation of startups - BioPharma Dive
(THRD) Technical Data - Stock Traders Daily
Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Third Harmonic Bio's chief medical officer sells $40,095 in stock - Investing.com
A new biotech, built around protein design, springs from David Baker’s lab - BioPharma Dive
Down -18.64% in 4 Weeks, Here's Why Philips (PHG) Looks Ripe for a Turnaround - MSN
Where are the Opportunities in (THRD) - Stock Traders Daily
Revvity Earnings Preview: What to Expect - MSN
Forbion follows string of startup exits with $2.2B fundraise - BioPharma Dive
(THRD) Trading Signals - Stock Traders Daily
Upstream prices $255M IPO in bid to challenge Amgen, AstraZeneca asthma drug - BioPharma Dive
Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive
Third Harmonic Bio: Nothing Stands Out (NASDAQ:THRD) - Seeking Alpha
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney - BioPharma Dive
How To Trade (THRD) - Stock Traders Daily
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise By Investing.com - Investing.com South Africa
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com
WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India
Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa
Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia
Third harmonic bio executive sells over $140k in stock - Investing.com
Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World
Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily
23andMe faces Nasdaq delisting - MSN
Independent directors resign from 23andMe board after opposing move to privatize - Washington Times
23andMe Stock Falls as All Board Members Resign - Barron's
Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins
Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle
ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire
23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24
23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24
Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Can the Fed’s rate cut change biotech’s ‘new normal’? - BioPharma Dive
Finanzdaten der Third Harmonic Bio Inc-Aktie (THRD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):